Skip to content

Clinical trials

Hematologic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Italy Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20063
20076
20081
20095
20103
20115
20124
20134
20141
20151
20164
20174
20187
20196
20204
202110
20222
20235
20247
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting22
Unknown status17
Terminated13
Active, not recruiting7
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna5
Novartis Pharmaceuticals5
Azienda USL Reggio Emilia - IRCCS4
A.O. Ospedale Papa Giovanni XXIII3
Bellicum Pharmaceuticals3
Bristol-Myers Squibb3
Gruppo Italiano Malattie EMatologiche dell'Adulto3
Incyte Corporation3
Kura Oncology, Inc.3
Merck Sharp & Dohme LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms98
Leukemia12
Leukemia, Myeloid, Acute11
Multiple Myeloma11
Myelodysplastic Syndromes11
Neoplasms11
Lymphoma8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Lymphoma, Non-Hodgkin7
Graft vs Host Disease5

Trials

Showing 51 to 75 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.